Vaxart, Inc. (VXRT)
|52 Week Range||0.56-2.31|
|1y Target Est||-|
|DCF Unlevered||VXRT DCF ->|
|DCF Levered||VXRT LDCF ->|
|Debt / Equity||24.68%||Neutral|
Upgrades & Downgrades
Latest VXRT news
3 Biotech Blockbusters to Turn $5,000 Into $50,000
12 September 2023
Investing in biotech stock can provide investors with immense rewards but also substantial risks. The key is finding the right balance.
Bears are Losing Control Over VAXART, INC. (VXRT), Here's Why It's a 'Buy' Now
15 August 2023
After losing some value lately, a hammer chart pattern has been formed for VAXART, INC. (VXRT), indicating that the stock has found support.
Vaxart, Inc. (VXRT) Q2 2023 Earnings Call Transcript
3 August 2023
Start Time: 16:30 January 1, 0000 5:01 PM ET Vaxart, Inc. (NASDAQ:VXRT ) Q2 2023 Earnings Conference Call August 03, 2023, 16:30 PM ET Company Participants Andrei Floroiu - President and CEO James Cum...
VAXART, INC. (VXRT) Reports Q2 Loss, Tops Revenue Estimates
3 August 2023
VAXART, INC. (VXRT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19.
Why Is Vaxart (VXRT) Stock Down 25% Today?
7 June 2023
Vaxart (NASDAQ: VXRT ) stock is taking a beating on Wednesday as investors react to the company announcing a proposed public share offering. According to a press release from Vaxart, the company is ho...
These 2 Stocks Carry a Lot of Risk, but Their Upside Is Huge
24 April 2023
Novavax and Vaxart both were early favorites in the coronavirus vaccine race -- but the two companies fell behind. Since then, they've cut costs and shifted strategies.
Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for ...
17 March 2023
Company to provide a detailed overview of its norovirus clinical program
Vaxart, Inc. (VXRT) Q4 2022 Earnings Call Transcript
15 March 2023
Vaxart, Inc. (NASDAQ:VXRT ) Q4 2022 Earnings Conference Call March 15, 2023 4:30 PM ET Company Participants Brant Biehn - Senior Vice President, Business Operations Andrei Floroiu - Chief Executive Of...
Vaxart to Host Full Year 2022 Business Update and Financial Results Conference Call on March 15
8 March 2023
Conference call to begin at 4:30 p.m. ET